脑梗死后患者后期静脉补液治疗及口服药物治疗研究

Intravenous Rehydration and Oral Medication for Late Treatment of Cerebral Infarction Patients

目的对罹患脑梗死的患者进行后期静脉补液治疗和进行口服药物治疗的效果进行较为深入的研究。方法选择2018年12月-2019年12月吉林省通化市中心医院100例罹患脑梗死的患者,并将其分为观察组和对照组各50例。患者在分开使用不同治疗方案之前都先使用尼莫地平片联合血塞通片来稳定病情。待病情稳定后,观察组的患者还需要加用血塞通进行静脉滴注治疗,与此同时还需要加用口服药物长春西汀。对照组的患者则不加用任何治疗措施。经过了同样的治疗时间后,对两组患者的治疗效果以及脑梗死复发率进行记录。结果对比两组患者使用不同治疗方式的治疗效果数据,观察组治疗效果显著优于对照组(P<0.05)。对比两组患者使用不同治疗方式后的疾病复发概率。对照组复发7例,复发概率为14%,观察组复发1例,复发概率为2%,观察组优于对照组(P<0.05)。结论这就意味着使用静脉补液治疗和口服药物治疗方式来进行治疗的患者治疗效果要好一些,因此该种治疗方式值得进行推广与使用。

Objective To study effect of intravenous rehydration and oral medication for patients with cerebral infarction.Methods The paper chose 100 patients with cerebral infarction in Tonghua Central Hospital of Jilin from December 2018 to December 2019,and divided them into observation group and control group,with 50 cases in each group,treated with nimodipine tablets combined with Xuesaitong tablets to stabilize their condition before different treatment schemes separately.After condition was stable,patients in observation group were added with Xuesaitong for intravenous drip treatment,and vinpocetine an oral drug.Patients in control group were treated with no treatment.After same treatment time,treatment effect and recurrence rate of cerebral infarction between two groups was recorded.Results Data comparison between two groups with different treatment methods showed,treatment effect of observation group was significantly better than control group(P<0.05).Recurrence probability of disease comparison between two groups after different treatment methods showed,7 cases recurred in control group,with recurrence probability pf 14%.1 case recurred in observation group,with recurrence probability of 2%.Effect of bservation group was better than control group(P<0.05).Conclusion Intravenous rehydration therapy and oral drug therapy can achieve better effect,which is worthy of promotion and application.